跳到主要导航 跳到搜索 跳到主要内容

Serum level of galectin-3 and its clinical significance in patients with chronic Keshan disease

  • Yuxiao Sun
  • , Xin Liu
  • , Dengfeng Gao
  • , Xin Dong
  • , Canzhan Zhu
  • , Zhenhua Han
  • , Yiqiang Yuan
  • , Yanhe Zhu
  • , Xiaolin Niu
  • The Second Affiliated Hospital of Xi'an Jiaotong University
  • Henan Provincial People's Hospital

科研成果: 期刊稿件 › 文章 › 同行评审

1 引用 (Scopus)

摘要

Objective: Keshan disease (KD) is a fatal endemic dilated cardiomyopathy with unclear etiology and pathogenesis, and a high mortality in China. Pathologic studies confirmed that different degree of myocardial fibrosis existed in various types of KD. Myocardial fibrosis is an important contributor to the pathophysiology of left ventricular remodeling. Recently, galectin-3 (Gal-3) as a marker of cardiac fibrosis and heart failure was approved by the US FDA. The aim of this study was to evaluate the changes of serum level of Gal-3 in chronic KD (CKD) and their clinical implications. Methods: The levels of serum Gal-3 were measured by using enzyme-linked immunosorbent assay (ELISA) in 37 CKD patients and 32 healthy controls. Echocardiography was used to determine parameter of left ventricular ejection fraction (LVEF) and left ventricular end-diastolic dimension (LVEDD). Results: The serum concentration of Gal-3 ([95.81±18.99] ng/ml versus [48.16±11.09] ng/ml, t=6.906, P<0.001) and LVEDD ([60.46±7.63] mm versus (42.69±10.66) mm, t=3.61, P<0.01) were significantly higher, while LVEF ([42.69±10.66]% versus [62.16±6.38]%, t=4.679, P<0.01) were significantly lower in CKD patients compared with healthy controls. A negative correlation was found between elevated Gal-3 and lower LVEF ( r=-0.882, P<0.001) and a positive correlation was found between elevated Gal-3 levels and enlarged LVEDD ( r=0.834, P<0.001) or higher NYHA class ( r=0.854, P<0.01) in CKD patients. Conclusion: Serum concentration of Gal-3 is strongly correlated with poorer left ventricular systolic function, enlarged LVEDD and higher New York Heart Association (NYHA) class, which may provide indirectly diagnostic information on myocardial fibrosis and heart function in CKD patients.

源语言英语
页(从-至)152-159
页数8
期刊Journal of Medical Colleges of PLA
卷28
期3
DOI
出版状态已出版 - 6月 2013
已对外发布是

学术指纹

探究 'Serum level of galectin-3 and its clinical significance in patients with chronic Keshan disease' 的科研主题。它们共同构成独一无二的学术指纹。

引用此